Publications found:
253,269
Sort by:
DISHMAN - Back To Basics
US$ 90.00
We reiterate our Underperform rating on Dishman despite it’s higher than expected Q4 FY11 result. The result was ...
May 2011
5 pages
Lupin Looses Combivir – A Big Blow To An Already Weak FY12 Pipeline
US$ 140.00
... for generic Combivir (Lamivudine + Zidovudine). With this approval, Teva has been granted and Lupin has ... ), Teva will launch its generic in Q4CY11. Lupin will be able to enter only after the 180 ... all other generics as well. We reiterate our Underperform on Lupin with target price of Rs.360 on the back of (1) ...
May 2011
2 pages
Clinical Trials Market in Russia
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00 The clinical trials market in Russia is one of the vibrant sectors in...
May 2011
50 pages
China Health Management Survey Report, 2011
US$ 1,400.00
With the development of Chinese economy, improvement of living standards and intensified aging population, Chinese people have growing demand for health management. In China, many industries are activ...
May 2011
62 pages
Minimally Invasive Surgical Devices, World Market
US$ 3,500.00
Price (Single User PDF): US$ 3,500.00 Price (Global Site License): US$ 7,000.00 Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It i...
May 2011
150 pages
Orthopedic Biomaterials, The World Market
US$ 3,995.00
Price (Single User PDF): US$ 3,995.00 Price (Global Site License): US$ 7,995.00 Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fractur...
May 2011
250 pages
Drug Combinations: New Rules, New Opportunities
US$ 895.00
Single symptom. Single illness. Single drug.
For years, drug therapy has been built on that basic equation. Yet as genomic biology sheds light on the astonishing intricacy of disease patholo...
May 2011
48 pages
Keys for Pharma Success: Integrating Social
US$ 595.00
Pharma companies began their journey in social media over four years ago with a single initiative, often a Twitter account. Subsequently, they have embarked upon a process of layering their digital fo...
May 2011
51 pages
Market Access Europe: It's Not Just About Price
US$ 795.00
“May you live in interesting times.” Considered a curse by some, the saying could also be a blessing—especially when it comes to the evolving world of market access in Europe. Given its complex geo-po...
May 2011
71 pages
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011
US$ 11,495.00
... 2010, the European market for cardiac rhythm management, electrophysiology, and ablation devices was valued at over €2.3 billion ($3.09 billion). The fastest ... as Biotronik, Boston Scientific, Medtronic and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed ...
May 2011
462 pages
Vitamins and Dietary Supplements in Indonesia
US$ 900.00
Vitamins and dietary supplements continued to record healthy double-digit current retail value growth in 2010, with sales being boosted by the increasing popularity of preventive medicine, especially...
May 2011
44 pages
Medicated Skin Care in Kazakhstan
US$ 990.00
... on high-priced medicines, such as medicated skin care. Changing perceptions of beauty have also made people less... Euromonitor International's Medicated Skin Care in Kazakhstan report offers a comprehensive guide ... and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy ...
May 2011
24 pages
Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021
US$ 2,325.00
... and a research interview (shown in the accompanying lists). Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 shows you revenue ... technologies in development, assessing potential among the R&D product candidates for ACS You will investigate competition and opportunities influencing the industry ...
May 2011
132 pages
Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021
US$ 2,325.00
... helps you to understand this industry and its potential. Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021 shows you revenue ... platforms You will assess the activities of the pharma industry in genomics research and the importance of public-private partnerships - industry-academia ...
May 2011
117 pages
Future of White Biotechnology in China
US$ 14,897.00
... Analysis on the development bottleneck and investment opportunities of White Biotechnology in China will be more detailed. Analysis on bio-fuels and ... and development environments of China’s White Biotechnology will be more detailed. SWOT analysis on analysis of China’s white biotechnology will more detailed. ...
May 2011
288 pages
Healthcare IT Market in Emerging Economies (2010 - 2015)
US$ 5,650.00
... quality healthcare delivery by growing aging population, and increase in chronic disease patient population is driving the increased adoption of IT solutions in the emerging markets. The Healthcare IT markets in emerging economies is expected to grow from $5.3 billion in 2010 to $10.9 billion in 2015, at an estimated CAGR of 15.3% from 2010 to 2015. The hardware segment dominates the healthcare IT market in emerging ...
May 2011
259 pages
Brazil Biomaterial Market (2010 – 2015)
US$ 5,650.00
... Brazil biomaterial market. Plus, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the biomaterials market ...
May 2011
179 pages
Global Biomaterial Market (2010 - 2015)
US$ 5,650.00
... biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market ... , at a CAGR of 12.7% (2010 to 2015) because the market is relatively mature compared to other product markets. Cardiovascular biomaterial is the second-highest market, and contributed 36.1% to the global biomaterial market in 2010. With the ...
May 2011
417 pages
Competitor Analysis Influenza Vaccines
US$ 718.00
... of seasonal and pandemic influenza disease. In addition, the report lists company-specific product portfolios and R&D pipelines of influenza vaccines on the market and in R&D. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of ...
May 2011
123 pages
Global DNA & Gene Chip (Microarray) Market (2010 - 2015)
US$ 5,650.00
... the largest share – 98% – of the global DNA & gene chip market in 2010. Gene Expression currently forms the largest application market as gene expression products are used in a wide ... diagnostics, biodefense, and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis and treatment application ...
May 2011
331 pages
China Sourcing Report: Medical Products & Supplies
US$ 350.00
PDF Price: US$ 350.00 Published Price: US$ 395.00 Prices of medical products and supplies from China are anticipated to increase in coming months due mainly to high material costs. Spending for vario...
May 2011
75 pages
Single Cell Omics 2011
US$ 3,907.00
... that will enable researchers to generate more data from smaller numbers of cells, which can be enabling in cases of precious samples. The result of this ... of the fittest requires a detailed understanding of this emerging market. Single Cell Omics 2011 explains the key technologies, applications, unmet needs ...
April 2011
167 pages
Overview of Bacillus Cereus in China
US$ 1,126.00
... and many raw and processed foods. Overview of Bacillus Cereus in China is CCM International's first edition report on Chinese bacillus cereus industry, finished in April 2011. This intelligent ...
April 2011
14 pages
Overview of Bacillus Subtilis in China
US$ 1,126.00
... which 5 are for technical, 17 for formulations. Overview of Bacillus subtilis in China is CCM International's first edition report on Chinese bacillus subtilis industry, finished in April 2011. This intelligent ...
April 2011
15 pages
Clinical Nutrition Products, 4th Edition
US$ 3,995.00
This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition:Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux...
April 2011
220 pages
Middle East and Africa Pharma Sector Forecast to 2012
US$ 1,200.00
Single User PDF Format: US$ 1,200.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,400.00
CD-ROM: US$ 1,400.00 of market defining regulations and increasing expenditure on healthca...
April 2011
80 pages
China Healthcare Sector Analysis
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,100.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 Chinese healthcare industry is entering into a new phase with the advanced...
April 2011
95 pages
South African Healthcare Market Analysis
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00 South African Healthcare industry is one with a lot of scope, which i...
April 2011
75 pages
US Stem Cell Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,400.00
Hard Copy: US$ 1,000.00
CD-ROM: US$ 900.00 The stem cell market has been growing at a fast pace for the past few yea...
April 2011
65 pages
UK Generics Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,100.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 The UK is one of the largest economies in the world. The per capita income and spending ha...
April 2011
55 pages
Global Alzheimer Prevalence and Drugs Demand
US$ 630.00
EXECUTIVE SUMMARY
The report on “Global Alzheimer Prevalence and Drugs Demand” includes the overall market for the treatment of Alzheimer, performance of drugs by sales and market share. In...
April 2011
37 pages
Women's Health Diagnostic Testing Markets
US$ 3,995.00
Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. However, during the past two...
April 2011
150 pages
US Oncologist Survey: Optimizing Treatment for Advanced Lung Cancer
US$ 1,200.00
... to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment ... with adenocarcinoma Former light smoker whose cancer is EGFR positive Treatment decisions for advanced stages of cancer are difficult to track as information ...
April 2011
56 pages
Facial Rejuvenation Markets
US$ 3,500.00
Price (Single User PDF): US$ 3,500.00 Price (Global Site License): US$ 7,000.00 The aging of the population, namely the baby boomer demographic segment is driving the market for facial rejuvenation p...
April 2011
250 pages
Out of Pocket Healthcare Spending 2011
US$ 1,995.00
Price (Single User PDF): US$ 1,995.00 Price (Global Site License): US$ 3,990.00 The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflatio...
April 2011
85 pages
US Oncologist Survey: Optimizing Treatment for Large Cell Lymphoma
US$ 500.00
... that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progressions reveal ... Barriers to optimal patient care Confidence in treatment Data has been synthesized to show all responses and direct quotes from the oncologists ...
April 2011
35 pages
US Oncologist Survey: Optimizing Treatment for Advanced Non-Hodgkin's Lymphoma
US$ 1,200.00
... . This primary research provides the oncology prescribing information that you are missing, directly from high-prescribing US oncologists on the treatment of specific patient types. Patient situations: Asymptomatic indolent lymphoma Elderly infirm patient with advanced follicular lymphoma Relapsed ...
April 2011
61 pages
Biosimilars Update
US$ 695.00
From Canada and the US to Japan, the EU and Australia, regulators around the world are establishing guidelines that will pave the way for competition between biosimilars and costly biologics. For many...
April 2011
140 pages
European Markets for Patient Monitoring Devices and Equipment
US$ 11,495.00
EXECUTIVE SUMMARY 1.1 Total European Patient Monitoring Markets In 2010, the European patient monitoring markets recovered from the global economic recession of ... market maturity resulting from low birthing rates across Europe. Newer, less invasive technologies are emerging within both segments and are ...
April 2011
528 pages
European Markets for Patient Monitoring Devices and Equipment 2011 (15 Countries)
US$ 11,495.00
... and evolving clinical practices drive growth. The European markets for patient monitoring devices covers Austria, Benelux, France, Germany, Italy, ... Medical International, Nihon Kohden and Philips Healthcare, lead the market, among many others. This report provides a comprehensive and detailed ...
April 2011
497 pages
